Western blot and gelatin zymography analyses revealed that Myr treatment effectively suppressed MMP-2 and MMP-9 activity in MDA-Mb-231Br breast cancer cells summarized in Table 2. This evidence concerns the gene MMP9 and breast carcinoma.